BETA
BETA
Gilead Sciences
GILD73
$77.01arrow_drop_up0.65%$0.50
S&P500
GILD73
$77.01
arrow_drop_up0.65%| Key Stats | |
|---|---|
| Open | $76.03 |
| Prev. Close | $76.51 |
| EPS | 0.36 |
| Next Earnings Date | Sep 26, 2024 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 75.75 | 78.29 |
| 52 Week Range | 62.07 | 87.87 |
| Ratios | |
|---|---|
| EPS | 0.36 |
| Fundamentals | |
|---|---|
| Industry average yield | 2.86% |
| Last Dividend pay date | Jun 27, 2024 |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
GILDarrow_drop_up0.65%
US Healthcare Sectorarrow_drop_up0.95%
US Marketarrow_drop_up1.17%
warning
GILD / Market
GILD lose to the US Market which returned 1.17% over the last twenty four hours.warning
GILD / Healthcare Sector
GILD lose to the US Healthcare sector which returned 0.95% over the last twenty four hours.Gilead Sciences (GILD) Statistics
Keep an eye on Gilead Sciences
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How much debt does Gilead Sciences (GILD) have?
Gilead Sciences (GILD) has a total debt of $25.19B. The net debt, which accounts for cash and cash equivalents against the total debt, is $20.48B.
help
How has Gilead Sciences (GILD) stock's performance compared to its sector and the market over the past year?
Over the past year, Gilead Sciences (GILD) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.05%, Gilead Sciences has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 51.99%, it has fallen short of the market average. This comparison highlights Gilead Sciences 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Gilead Sciences (GILD) stock?
The PE (Price to Earnings) ratio of Gilead Sciences (GILD) is currently 213.92. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help
What is the EPS of Gilead Sciences (GILD) stock?
The Earnings Per Share (EPS) for Gilead Sciences (GILD), calculated on a diluted basis, is $0.36. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Gilead Sciences (GILD) stock?
The operating margin for Gilead Sciences (GILD) is 34.43%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Gilead Sciences (GILD) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Gilead Sciences (GILD) is $9.64B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.